Vicente Anido Jr
CIK 1207633 · Chief Executive Officer · last filed 2021-02-25
Vicente Anido Jr is a Chief Executive Officer who has filed 56 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider had shares withheld for taxes covering $26.6K of AERI on Feb 25, 2021. Across all open-market trades the lifetime net is −$11.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.2K across reported positions. 3 SEC filings were submitted jointly with QLT INC/BC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AERI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
CORONA DEL MAR, CA 92625
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AERIE PHARMACEUTICALS INC (AERI) Delisted | Chief Executive Officer | 243,896 | $15.25 | $3.72M | -$11.66M | 22 | 2021-02-25 |
| Assertio Therapeutics, Inc (DEPO) Delisted | Director | 4,403 | — | — | $0 | 6 | 2016-05-13 |
| QLTI | Director | — | $27.98 | — | $0 | 2 | 2013-07-17 |
| ISTA PHARMACEUTICALS INC (ISTA) Delisted | President & CEO | 500,659 | — | — | $315.1K | 23 | 2012-05-10 |
| AHG | Director | 5,333 | $1.35 | $7.2K | $0 | 1 | 2007-05-07 |
Recent Filings
56 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-25 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Tax (F) | −1,700 | -$26.6K | EDGAR |
| 2021-02-09 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Tax (F) | −7,954 | -$140.7K | EDGAR |
| 2021-02-08 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Grant (A) | +28,000 | $0 | EDGAR |
| 2020-05-18 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Tax (F) | −4,746 | -$70.5K | EDGAR |
| 2020-02-25 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Tax (F) | −2,579 | -$53.7K | EDGAR |
| 2020-02-11 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Tax (F) | −3,256 | -$66.7K | EDGAR |
| 2020-02-10 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Mixed | +30,250 | $0 | EDGAR |
| 2019-09-09 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Buy (P) | +26,250 | $499.0K | EDGAR |
| 2019-05-17 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Mixed | +28,026 | -$168.0K | EDGAR |
| 2019-04-15 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Tax (F) | −2,612 | -$109.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.